The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management

Clinical trials in the past decade have established the antitumor effects of immune checkpoint inhibition as a revolutionary treatment for cancer. Namely, blocking antibodies to cytotoxic T-lymphocyte antigen 4 and programmed death 1 or its ligand have reached routine clinical use. Manipulation of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Girotra, Monica, Hansen, Aaron, Farooki, Azeez, Byun, David J, Min, Le, Creelan, Ben C, Callahan, Margaret K, Atkins, Michael B, Sharon, Elad, Antonia, Scott J, West, Pamela, Gravell, Amy E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054022/
https://www.ncbi.nlm.nih.gov/pubmed/30057972
http://dx.doi.org/10.1093/jncics/pky021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054022/
https://www.ncbi.nlm.nih.gov/pubmed/30057972
http://dx.doi.org/10.1093/jncics/pky021

Ejemplares similares